Aaron Cowen, 10% Owner, Director at Benitec Biopharma Inc. (BNTC), bought 900,000 shares at $13.00 ($11.7M) on 2025-03-26, disclosed to the SEC on 2025-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 106,200 | $1.4M | 11.8% |
| 2 | $13.00 | 793,800 | $10.3M | 88.2% |
| Total | $13.00 avg | 900,000 | $11.7M | 100% |
| Filing → |
| PROK | BUY | 2022-09-08 | $49K | — | Filing → |
| PROK | BUY | 2022-09-01 | $34K | — | Filing → |